4//SEC Filing
Levine James E. 4
Accession 0001628280-22-005792
CIK 0001213037other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 6:40 PM ET
Size
5.5 KB
Accession
0001628280-22-005792
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Stock Options
2022-03-09+170,016→ 560,016 totalExercise: $2.50Exp: 2032-03-09→ Common Stock (170,016 underlying)
Footnotes (1)
- [F1]42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 6:40 PM ET
- Size
- 5.5 KB